Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 3 |
2024 | 1 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Effectiveness and Safety of Guselkumab for the Treatment of Psoriasis in Real-World Settings at 52 weeks: A Retrospective, Observational, Multicenter Study from China.
Dermatol Ther (Heidelb). 2023 Feb;13(2):477-485. doi: 10.1007/s13555-022-00869-w. Epub 2022 Dec 8.
Dermatol Ther (Heidelb). 2023.
PMID: 36481840
Free PMC article.
Rapid and sustained resolution in generalized pustular psoriasis with IL-17A inhibitors required high adherence: a 96-week analysis in a real-life setting.
Hu K, Liu Y, Liu Y, Jian L, Duan Y, Liu R, Zhang H, Chen J, Zhang M, Kuang Y.
Hu K, et al.
Int J Dermatol. 2024 Apr 17. doi: 10.1111/ijd.17163. Online ahead of print.
Int J Dermatol. 2024.
PMID: 38632699
Item in Clipboard
Educational service correlates with greater improvement and adherence in psoriasis patients responding to ixekizumab.
Hu K, Shen M, Zhang M, Kuang Y.
Hu K, et al.
J Dtsch Dermatol Ges. 2023 Aug;21(8):900-902. doi: 10.1111/ddg.15121. Epub 2023 Jul 21.
J Dtsch Dermatol Ges. 2023.
PMID: 37480160
No abstract available.
Item in Clipboard
[Schulungsangebot korreliert mit stärkerer Verbesserung und höherer Adhärenz bei Psoriasis-Patienten, die auf Ixekizumab ansprechen].
Hu K, Shen M, Zhang M, Kuang Y.
Hu K, et al.
J Dtsch Dermatol Ges. 2023 Aug;21(8):900-903. doi: 10.1111/ddg.15121_g.
J Dtsch Dermatol Ges. 2023.
PMID: 37574673
German.
No abstract available.
Item in Clipboard
Cite
Cite